Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EPRX
EYPT
Add up to 3 more stocks
EPRX
Eupraxia Pharmaceuticals Inc.
-0.06%
$7.74-0.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$259.14M
52W Range
$5.25 - $9.32
EYPT
EyePoint Pharmaceuticals, Inc.
+0.63%
$3.17+0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$265.78M
52W Range
$3.05 - $19.11
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.55 | 1.60 |
| P/S Ratio | N/A | 95.29 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 93.4% |
| Operating Margin | 0.0% | -776.0% |
| Net Margin | 0.0% | -10994.7% |
| ROE | -38.3% | -184.3% |
| ROA | -36.0% | -134.4% |
| ROIC | -43.6% | -170.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.00 | 4.50 |
| Quick Ratio | 16.00 | 4.46 |
| Debt/Equity | 0.01 | 0.13 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.